The number arrived with a brass band this week: American life expectancy at birth, 79. Up from 78.4 in 2023. Nearly back to the 78.9 the country cleared a decade ago, before the pandemic erased a decade’s worth of stagnation in eighteen months. The editorialists are already picking out their victory laps. The free-market champions are strapping on their medals. Capitalism’s faithful are lining up to take a bow. Don’t take the bait.
A gain of six-tenths of a year, after the worst mass-death event in modern American history, is not a public-health triumph. It is the floor. It is the country crawling back to where it already was — and stopping, again, at a number that still leaves the United States ranked somewhere in the bottom half of wealthy democracies, behind most of Europe, behind Japan, behind South Korea, behind every country whose elected officials decided long ago that keeping citizens alive past seventy was a basic obligation of state rather than a happy byproduct of consumer choice. Changes in the statistic from year to year reflect changes in public health — and the public-health disasters this country has tolerated for decades.
Look at what the rebound is actually made of. The CDC’s own breakdown names the contributors: declining deaths from unintentional injuries (overdoses coming down from their peak), from Covid fading, from heart disease, from cancer, from homicide. Two of the five — overdoses and Covid — are not improvements. They are the absence of disasters. Counting the absence of catastrophe as progress is the same kind of bookkeeping that lets a hospital declare victory when it stops losing patients. The overdoses were the predictable residue of an opioid crisis manufactured, marketed, and distributed by the very pharmaceutical industry now being thanked for life-extending breakthroughs. Counting its retreat as a win is awarding the arsonist credit for the rainfall.
Then look at what the editorial boards would rather you not look at. The same CDC data notes a small uptick in flu deaths — last winter was a bad one — and a small uptick in deaths from nutritional deficiencies. That second number is the one nobody wants to touch. In the richest country in human history, more people are dying of malnutrition. Not in a famine zone. In the United States, in 2024. A category of mass suffering that has no business existing in a country this wealthy. The fact that the gain of six-tenths of a year survived this at all tells you how shallow the foundation is.
The deeper story is the one the editorial writers refuse to print. Age-adjusted mortality is down 17% since 2000 and 30% since 1980 — those numbers are real. Heart-disease deaths down 39% since 2000 and 62% since 1980; cancer deaths down 31% since 2000 and 33% since 1980. Real. But read them as a trajectory rather than a banner. The 1980-to-2000 stretch did most of the work — the smoking decline won by regulation and litigation against an industry that lied about cancer for decades, the statin era, the first wave of cancer screening, the public-health campaigns that drove down cardiovascular mortality across the developed world. Since 2000 the curve has flattened, faltered, dipped, recovered a sliver, and flattened again. The trend is not acceleration. The trend is exhaustion. The chronic-disease surge — diabetes, obesity — is a runaway product of a food system engineered for profit, not health.
And the credit the editorial assigns — to the same capitalist machinery that charges an American patient hundreds of dollars a month for insulin, that lets a GLP-1 prescription function as a luxury good, that bills an American hospital ten times what a European hospital bills for the same stent, that sets the price of statins and immunotherapies for maximum extraction rather than maximum access — is a fairy tale about who actually pays for these gains. Statins are off-patent. Immunotherapies are publicly subsidized research translated into private profit. The basic science sits in NIH-funded labs; the clinical trials sit in academic medical centers; the delivery sits in a tax-advantaged, employer-sponsored, catastrophic-insurance-shaped system that has, this very year, watched Congressional majorities vote to take food assistance from the lowest-income Americans while celebrating the resulting mortality statistics as proof that the system works. The recovery is real. The system that made the collapse necessary is unchanged.
The 79 is real. The triumph is fake. The political irony is that America’s capitalist system and pharma industry are profiting from life-extending treatments for cancer and other diseases even as they continue to manufacture the crises that kill Americans in the first place — a sick-care economy that needs sick people. America’s capitalist apologists, on whatever side, should save their applause for the next epidemic. A country that needs an editorial board to point at a tenth of a year above where it sat in 2014 and call it victory is a country that has stopped demanding more of itself.
